Exchange: NASDAQ·Updated 07:30 PM EST

ADAG News

News
all
press releases
Adagene (NASDAQ:ADAG) Upgraded at Wall Street Zen
Wall Street Zen raised Adagene from a "sell" rating to a "hold" rating in a report on Saturday...
MarketBeat
Adagene (NASDAQ:ADAG) Upgraded at Wall Street Zen
Wall Street Zen raised Adagene from a "sell" rating to a "hold" rating in a report on Saturday...
MarketBeat
More News
City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States, and Adagene Inc. (Adagene) (Nasdaq: ADAG), a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel antibody-based therapies, today...
Business Wire
Adagene (ADAG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks
Here is how Adagene Inc. Sponsored ADR (ADAG) and Contineum Therapeutics, Inc. (CTNM) have performed compared to their sector so far this year.
Zacks
Adagene Inc. Sponsored ADR (NASDAQ:ADAG - Get Free Report) saw a significant increase in short interest in April. As of April 15th, there was short interest totaling 411,325 shares, an increase of 477.3% from the March 31st total of 71,244 shares. Approximately 1.1% of the company's shares are...
MarketBeat
Shares of Adagene Inc. Sponsored ADR (NASDAQ:ADAG - Get Free Report) have been given an average recommendation of "Buy" by the five brokerages that are currently covering the stock, MarketBeat...
MarketBeat
Adagene Inc. Sponsored ADR (NASDAQ:ADAG - Free Report) - Equities research analysts at HC Wainwright issued their FY2026 earnings estimates for Adagene in a research report issued on Tuesday, April 7th. HC Wainwright analyst A. He forecasts that the company will post earnings of ($0.37) per share fo...
MarketBeat
Guggenheim raised their price target on Adagene from $9.00 to $10.00 and gave the stock a "buy" rating in a research report on Monday...
MarketBeat
Adagene priced the public offering of its American depository shares at $3.75 per ADS, representing a discount of nearly 19% from ADAG’s closing price on Wednesday.
Stocktwits
Adagene (NASDAQ:ADAG - Get Free Report) announced its earnings results on Wednesday. The company reported ($0.04) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.28...
MarketBeat

Advertisement|Remove ads.